|
US5194596A
(en)
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
|
US5350836A
(en)
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
US6180602B1
(en)
|
1992-08-04 |
2001-01-30 |
Sagami Chemical Research Center |
Human novel cDNA, TGF-beta superfamily protein encoded thereby and the use of immunosuppressive agent
|
|
JPH07258293A
(ja)
|
1994-03-23 |
1995-10-09 |
Asahi Chem Ind Co Ltd |
新規な蛋白質ならびにその製造方法
|
|
US6521227B1
(en)
|
1999-11-18 |
2003-02-18 |
Peter L. Hudson |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
|
US5994102A
(en)
|
1994-12-15 |
1999-11-30 |
Human Genome Sciences, Inc. |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
|
WO1996018730A1
(en)
|
1994-12-15 |
1996-06-20 |
Human Genome Sciences, Inc. |
Prostatic growth factor
|
|
ES2324433T3
(es)
|
1995-06-22 |
2009-08-06 |
St Vincent's Hospital Sydney Limited |
Tgf-beta novedoso similar a citocina.
|
|
US6696259B1
(en)
|
1995-11-13 |
2004-02-24 |
Licentia Ltd. |
Assays using glial cell line-derived neurotrophic factor receptors
|
|
KR19990067508A
(ko)
|
1995-11-13 |
1999-08-25 |
한누 사리올라 |
신경교 세포주 유래 신경영양성 인자 수용체
|
|
US6524802B1
(en)
|
1996-03-29 |
2003-02-25 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-14
|
|
JP2001500732A
(ja)
|
1996-09-11 |
2001-01-23 |
オーソ―マクニール・フアーマシユーチカル・インコーポレーテツド |
前立腺がんを治療するためのＴＮＦ―β様タンパク質、ならびに関連する核酸分子、医薬組成物および方法
|
|
CA2289116A1
(en)
*
|
1997-05-06 |
1998-11-12 |
Human Genome Sciences, Inc. |
Enterococcus faecalis polynucleotides and polypeptides
|
|
KR20010012826A
(ko)
|
1997-05-22 |
2001-02-26 |
세파론, 인코포레이티드 |
신경교 세포주-유래 향신경성 인자 수용체
|
|
WO1999006445A1
(en)
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-15
|
|
WO2000005259A1
(en)
|
1998-07-23 |
2000-02-03 |
Smithkline Beecham Corporation |
Secreted cysteine rich protein-6 (scrp-6)
|
|
WO2000020867A1
(en)
|
1998-10-01 |
2000-04-13 |
Alexey Vladimirovich Titievsky |
A novel ret-independent signaling pathway for gdnf
|
|
US6905817B1
(en)
|
1998-10-01 |
2005-06-14 |
Licestia Ltd. |
Ret-independent signaling pathway for GDNF
|
|
US6465181B2
(en)
|
1999-03-25 |
2002-10-15 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
|
US6974684B2
(en)
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
JP2002543841A
(ja)
|
1999-05-17 |
2002-12-24 |
バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー |
ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性
|
|
US6866851B1
(en)
|
1999-12-28 |
2005-03-15 |
Washington University |
GFRα1-RET specific agonists and methods therefor
|
|
EP2213743A1
(en)
|
2000-04-12 |
2010-08-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
ATE470863T1
(de)
|
2000-04-20 |
2010-06-15 |
St Vincents Hosp Sydney |
Diagnostischer assay mit makrophagenhemmendem zytokin-1 (mic-1)
|
|
AU2001288770A1
(en)
|
2000-09-08 |
2002-03-22 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
|
|
WO2002062999A2
(en)
|
2000-12-29 |
2002-08-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
AU2002250293B2
(en)
|
2001-03-09 |
2007-10-11 |
Arnason, Barry G. Mr |
Polymeric immunoglobulin fusion proteins that target low-affinity FCGammaReceptors
|
|
DK1385882T3
(da)
|
2001-05-11 |
2008-02-11 |
Amgen Inc |
Peptider og relaterede molekyler, der binder til TALL-1
|
|
GB0115195D0
(en)
|
2001-06-21 |
2001-08-15 |
Bae Systems Plc |
Split-pin drill jig
|
|
US20030053431A1
(en)
|
2001-09-10 |
2003-03-20 |
Lila Madour |
Method for performing handoff in a radio telecommunications network
|
|
US20060253913A1
(en)
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US7642242B2
(en)
|
2002-03-05 |
2010-01-05 |
Genentech, Inc. |
PRO34128 polypeptides
|
|
US20100285016A1
(en)
|
2002-03-05 |
2010-11-11 |
Genentech, Inc. |
PRO34128 nucleic acids
|
|
CA2478369A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Genentech, Inc. |
Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
|
|
CA2390820A1
(en)
|
2002-06-17 |
2003-12-17 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
|
US7919084B2
(en)
|
2002-06-17 |
2011-04-05 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
|
CN1241946C
(zh)
|
2002-07-01 |
2006-02-15 |
美国福源集团 |
对多种细胞具刺激增生作用的人血清白蛋白重组融合蛋白
|
|
EP1575512A4
(en)
|
2002-11-08 |
2007-08-29 |
Barnes Jewish Hospital |
METHOD AND COMPOSITIONS FOR THE EPITHELIAL CELL DIFFERENTIATION IN THE PROSTATE
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US9296820B2
(en)
|
2003-11-05 |
2016-03-29 |
Roche Glycart Ag |
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
|
|
CN1241941C
(zh)
*
|
2003-11-21 |
2006-02-15 |
中国科学院上海生命科学研究院 |
一种促进神经分化和抗细胞凋亡的蛋白质及其编码基因
|
|
EP2441466B1
(en)
|
2004-04-13 |
2014-07-23 |
St Vincent's Hospital Sydney Limited |
MIC-1 inhibiting agent
|
|
WO2005113585A2
(en)
|
2004-05-20 |
2005-12-01 |
Acceleron Pharma Inc. |
Modified tgf-beta superfamily polypeptides
|
|
WO2006078161A1
(en)
|
2005-01-24 |
2006-07-27 |
Pepscan Systems B.V. |
Binding compounds, immunogenic compounds and peptidomimetics
|
|
ES2543341T3
(es)
|
2005-09-13 |
2015-08-18 |
National Research Council Of Canada |
Métodos y composiciones para modular la actividad de células tumorales
|
|
TWI428448B
(zh)
|
2006-03-24 |
2014-03-01 |
Syntonix Pharmaceuticals Inc |
作為第九因子（ｆａｃｔｏｒ ｉｘ）原肽處理酶之ｐｃ５
|
|
US8974748B2
(en)
|
2007-04-05 |
2015-03-10 |
Corning Incorporated |
Dual inlet microchannel device and method for using same
|
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US7754689B2
(en)
|
2006-06-02 |
2010-07-13 |
Wyeth Llc |
Finger-1 peptide analogs of the TGF-β superfamily
|
|
JP2009544697A
(ja)
|
2006-07-26 |
2009-12-17 |
ペプスキャン システムズ ベー．フェー． |
免疫原性化合物及びタンパク質擬態物
|
|
MX2009000914A
(es)
|
2006-08-04 |
2009-06-18 |
Hannover Med Hochschule |
Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
|
|
RU2461569C2
(ru)
*
|
2006-10-19 |
2012-09-20 |
Дженентек, Инк. |
Агонистические антитела против notch3 и их применение для лечения notch3-ассоциированных заболеваний
|
|
CN101808672B
(zh)
|
2007-04-25 |
2013-05-01 |
干细胞旋转股份公司 |
干细胞系、其应用以及培养方法
|
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
|
US20100278843A1
(en)
|
2007-08-16 |
2010-11-04 |
St. Vincent's Hospital Sydney Limited |
Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
|
|
CN101896192A
(zh)
|
2007-10-09 |
2010-11-24 |
圣文森特医院悉尼有限公司 |
一种通过去除或灭活巨噬细胞抑制因子-1而治疗恶病质的方法
|
|
ES2543985T3
(es)
|
2007-10-22 |
2015-08-26 |
St Vincent's Hospital Sydney Limited |
Métodos de pronóstico
|
|
JP6157046B2
(ja)
|
2008-01-07 |
2017-07-05 |
アムジェン インコーポレイテッド |
静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法
|
|
WO2009087190A1
(en)
|
2008-01-08 |
2009-07-16 |
Roche Diagnostics Gmbh |
Means and methods for assessing the risk of patients presenting to emergency units based on gdf-15
|
|
CA2711503A1
(en)
|
2008-01-08 |
2009-07-16 |
Biogenerix Ag |
Glycoconjugation of polypeptides using oligosaccharyltransferases
|
|
US8718994B2
(en)
|
2008-04-09 |
2014-05-06 |
Transtech Pharma, Llc |
Ligands for the GLP-1 receptor and methods for discovery thereof
|
|
WO2009141357A1
(en)
|
2008-05-20 |
2009-11-26 |
Roche Diagnostics Gmbh |
Gdf-15 as biomarker in type 1 diabetes
|
|
JP2011528115A
(ja)
|
2008-07-14 |
2011-11-10 |
エフ．ホフマン−ラ ロシュ アーゲー |
心不全を有する患者の診断、モニター及び治療の選択のためのマルチマーカーパネル
|
|
WO2010019263A2
(en)
|
2008-08-15 |
2010-02-18 |
Genzyme Corporation |
Soluble flt constructs for treating cancers
|
|
JP5444363B2
(ja)
|
2008-10-31 |
2014-03-19 |
セントビンセンツ ホスピタル シドニー リミテッド |
慢性腎疾患における予後判定の方法
|
|
EP2350265B1
(en)
|
2008-10-31 |
2019-04-17 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
|
|
EP2209003A1
(en)
|
2009-01-16 |
2010-07-21 |
F. Hoffmann-Roche AG |
Means and methods for differentiating between fibrosis and cirrhosis
|
|
EP2211182A1
(en)
|
2009-01-16 |
2010-07-28 |
Roche Diagnostics GmbH |
Method for the assessment of severity of liver cirrhosis
|
|
AU2010213575B2
(en)
|
2009-02-12 |
2013-11-14 |
Stryker Corporation |
Peripheral administration of proteins including TGF-beta superfamily members for systemic treatment of disorders and disease
|
|
GB0902737D0
(en)
|
2009-02-19 |
2009-04-01 |
Univ Gent |
GDF15 as a differential marker for spondyloarthropathy
|
|
JP5841845B2
(ja)
|
2009-02-24 |
2016-01-13 |
ソーク・インステチュート・フォー・バイオロジカル・スタディーズＳａｌｋ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｉｏｌｏｇｉｃａｌ Ｓｔｕｄｉｅｓ |
ＴＧＦ−βスーパーファミリーのデザイナーリガンド
|
|
WO2010129503A1
(en)
|
2009-05-05 |
2010-11-11 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
|
JP2012532608A
(ja)
|
2009-07-08 |
2012-12-20 |
アムジェン インコーポレイテッド |
ＣＨ３ドメイン界面操作を通じた、安定でそして凝集しない抗体Ｆｃ分子の設計
|
|
US20130323835A1
(en)
|
2009-07-15 |
2013-12-05 |
Zirus, Inc. |
Mammalian Genes Involved in Infection
|
|
US20120309697A1
(en)
|
2009-10-28 |
2012-12-06 |
Samuel Norbert Breit |
Methods of diagnosing and prognosing colonic polyps
|
|
EP2496601B1
(en)
|
2009-11-05 |
2017-06-07 |
F. Hoffmann-La Roche AG |
Methods and composition for secretion of heterologous polypeptides
|
|
WO2011064758A2
(en)
|
2009-11-30 |
2011-06-03 |
Pfizer Limited |
Fusion protein
|
|
US20120321557A1
(en)
|
2010-02-26 |
2012-12-20 |
Forerunner Pharma Research Co., Ltd. |
Anti-icam3 antibody and use thereof
|
|
US9212221B2
(en)
|
2010-03-03 |
2015-12-15 |
Detroit R & D, Inc. |
Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
|
|
JP5791335B2
(ja)
|
2010-04-07 |
2015-10-07 |
花王株式会社 |
オルガノポリシロキサン化合物の製造方法
|
|
US20130202564A1
(en)
|
2010-04-09 |
2013-08-08 |
University Of Southern California |
Systems and Methods of Cell Activated, Controlled Release Delivery of Growth Factors for Tissue Repair and Regeneration
|
|
EP2383571A1
(en)
|
2010-05-02 |
2011-11-02 |
Prof. Hess Medical Consulting GmbH |
Growth differntioation factor 15 (GDF 15) for risk prediction of diabetic foot ulcer
|
|
CN108387744A
(zh)
|
2010-08-26 |
2018-08-10 |
弗·哈夫曼-拉罗切有限公司 |
生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
|
|
US9243057B2
(en)
*
|
2010-08-31 |
2016-01-26 |
The Regents Of The University Of California |
Antibodies for botulinum neurotoxins
|
|
EP2439535A1
(en)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnosis of diabetes related heart disease and GDF-15 and Troponin as predictors for the development of type 2 diabetes mellitus
|
|
EP2694092B1
(en)
|
2011-04-08 |
2017-01-04 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
|
|
EP3415528B1
(en)
|
2011-04-13 |
2021-05-26 |
Bristol-Myers Squibb Company |
Fc fusion proteins comprising novel linkers or arrangements
|
|
AR086823A1
(es)
|
2011-06-30 |
2014-01-22 |
Genentech Inc |
Formulaciones de anticuerpo anti-c-met, metodos
|
|
TWI687439B
(zh)
|
2011-06-30 |
2020-03-11 |
中外製藥股份有限公司 |
異源二聚化多胜肽
|
|
WO2013012648A1
(en)
*
|
2011-07-15 |
2013-01-24 |
Emory University |
Gdf15 in diagnostic and therapeutic applications
|
|
EP3683228A3
(en)
|
2012-01-26 |
2020-07-29 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
|
CA2862516C
(en)
|
2012-03-27 |
2023-02-14 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
EP2863910B1
(en)
|
2012-06-20 |
2020-03-11 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
|
WO2014000042A1
(en)
|
2012-06-27 |
2014-01-03 |
Prince Henry's Institute Of Medical Research |
COMPOSITIONS AND METHODS FOR MODIFYING TGF-β FAMILY LIGANDS
|
|
UY34905A
(es)
*
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
|
HK1210192A1
(en)
*
|
2012-07-19 |
2016-04-15 |
Alethia Biotherapeutics Inc. |
Anti-siglec-15 antibodies
|
|
PE20150645A1
(es)
|
2012-08-08 |
2015-05-11 |
Roche Glycart Ag |
Proteinas de fusion de interleuquina 10 y usos de las mismas
|
|
JO3462B1
(ar)
*
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
|
RS59045B1
(sr)
|
2012-09-26 |
2019-08-30 |
Univ Wuerzburg J Maximilians |
Monoklonalna antitela za faktor 15 rasta i diferencijacije (gdf-15)
|
|
WO2014066590A1
(en)
|
2012-10-24 |
2014-05-01 |
Research Development Foundation |
Jam-c antibodies and methods for treatment of cancer
|
|
US20150376294A1
(en)
|
2012-12-03 |
2015-12-31 |
Rigshospitalet |
Anti-pad2 antibodies and treatment of autoimmune diseases
|
|
ES2791183T3
(es)
|
2012-12-21 |
2020-11-03 |
Aveo Pharmaceuticals Inc |
Anticuerpos anti-GDF15
|
|
DE102013100322A1
(de)
|
2013-01-14 |
2014-07-17 |
Claas Selbstfahrende Erntemaschinen Gmbh |
Schneidwerk
|
|
KR101993714B1
(ko)
|
2013-01-30 |
2019-06-28 |
엔지엠 바이오파마슈티컬스, 아이엔씨. |
대사 장애를 치료하는데 이용하기 위한 조성물과 방법
|
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
|
WO2014145016A2
(en)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
|
WO2014140374A2
(en)
*
|
2013-03-15 |
2014-09-18 |
Novo Nordisk A/S |
Monovalent cd27 antibodies
|
|
MX2015016978A
(es)
|
2013-06-10 |
2016-04-25 |
Merck Sharp & Dohme |
Proteinas de union a antigeno neutralizantes de citomegalovirus.
|
|
US9862752B2
(en)
|
2013-07-31 |
2018-01-09 |
Amgen Inc. |
Growth differentiation factor 15 (GDF-15) constructs
|
|
BR112017001183A2
(pt)
|
2014-07-21 |
2017-11-28 |
Novartis Ag |
tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado
|
|
AU2015296640B2
(en)
|
2014-07-30 |
2020-05-21 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
EP3701969A1
(en)
|
2014-10-31 |
2020-09-02 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
GB201512733D0
(en)
|
2015-07-20 |
2015-08-26 |
Genagon Therapeutics Ab |
Therapeutic agents for treating conditions associated with elevated GDF15
|
|
WO2017121865A1
(en)
|
2016-01-15 |
2017-07-20 |
Novo Nordisk A/S |
Mic-1 receptor and uses thereof
|
|
CN108697795A
(zh)
|
2016-02-29 |
2018-10-23 |
伊莱利利公司 |
Gfral受体疗法
|
|
US20170299608A1
(en)
|
2016-03-04 |
2017-10-19 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods for modulating body weight
|
|
MY194669A
(en)
|
2016-03-31 |
2022-12-12 |
Ngm Biopharmaceuticals Inc |
Binding Proteins and Methods of use Thereof
|
|
KR20190059312A
(ko)
|
2016-10-12 |
2019-05-30 |
얀센 바이오테크 인코포레이티드 |
Gdf15-유사 생물학적 활성의 조절제에 대한 스크리닝 방법
|
|
CN112912395B
(zh)
|
2018-08-20 |
2024-08-23 |
辉瑞公司 |
抗gdf15抗体、组合物和使用方法
|
|
US12398211B2
(en)
|
2020-06-04 |
2025-08-26 |
Daegu Gyeongbuk Institute Of Science And Technology |
GFRAL-antagonistic antibody and use thereof
|
|
EP4304647A1
(en)
|
2021-03-08 |
2024-01-17 |
MedImmune, LLC |
Antibodies directed against gdf-15
|
|
US20240182585A1
(en)
|
2021-03-31 |
2024-06-06 |
Cambridge Enterprise Limited |
Therapeutic inhibitors of gdf15 signalling
|
|
WO2022207785A1
(en)
|
2021-03-31 |
2022-10-06 |
Kymab Limited |
Antibodies to gfral
|
|
WO2023039359A1
(en)
|
2021-09-10 |
2023-03-16 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating cancer and tumor-related weight loss and cachexia
|
